Nonalcoholic Fatty Liver Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial to Assess the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD
This study will assess the efficacy and safety of 3 doses of PXL770 versus placebo after 12 weeks of treatment.
The study will be performed in patients with Nonalcoholic Fatty Liver Disease. The primary endpoint will be the assessment of the change in the percentage of liver fat mass (assessed by MRI-PDFF). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04031729 -
Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease
|
Phase 1/Phase 2 | |
Recruiting |
NCT03725631 -
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD
|
N/A | |
Active, not recruiting |
NCT05084404 -
Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease
|
Phase 2 | |
Completed |
NCT05081427 -
Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2
|
||
Recruiting |
NCT05430178 -
Metabolic Pathology of Pediatric NAFLD
|
N/A | |
Recruiting |
NCT04389593 -
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference
|
||
Active, not recruiting |
NCT05199948 -
Weight, Energy, Lipids, and the Liver (WELL) Study
|
N/A | |
Active, not recruiting |
NCT03696797 -
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
|
N/A | |
Terminated |
NCT02365233 -
Fatty Liver Study in Patients With Type II Diabetes
|
Phase 4 | |
Completed |
NCT05309642 -
Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study
|
N/A | |
Completed |
NCT04828551 -
Noninvasive Biomarkers of Metabolic Liver Disease 1.1
|
N/A | |
Completed |
NCT05792423 -
Conditionally Increased Output (CIO) Enhanced Ultrasound System
|
N/A | |
Not yet recruiting |
NCT06335771 -
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
|
N/A | |
Recruiting |
NCT02815891 -
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
|
||
Not yet recruiting |
NCT05908877 -
Cardio-Metabolic Risk Evaluation in Overweight and Obese Children
|
||
Not yet recruiting |
NCT04887766 -
Study on GS300 on NAFLD
|
N/A | |
Completed |
NCT03986684 -
Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease
|
||
Recruiting |
NCT05165706 -
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
|
N/A | |
Completed |
NCT04235205 -
Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease
|
Phase 2 | |
Recruiting |
NCT05680233 -
Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis
|
Phase 1 |